Forbion Closes €200 Million BioEconomy Fund to Drive Sustainable Biotechnology Innovation
Key Insights
Forbion (search) BioEconomy Fund I reached its hard cap of €200 million, establishing one of Europe's largest dedicated bioeconomy investment vehicles.
The fund targets biotechnology companies developing scalable solutions across food, agriculture, materials, and environmental technologies that can replace traditional industrial processes.
Strong institutional investor support from KfW Capital (search), Novo Holdings (search), and other major investors reflects growing confidence in science-led sustainability solutions.
Forbion (search), a leading European life sciences venture capital firm, has successfully closed its Forbion BioEconomy Fund I at its hard cap of €200 million, marking a significant milestone in sustainable biotechnology investment. The fund, which launched in 2024 with an initial target of €150 million, attracted strong institutional support and positions itself at the intersection of biotechnology and planetary health.
Strong Institutional Backing Drives Oversubscription
The fund drew commitments from major institutional investors across Europe and North America, including KfW Capital (search), Novo Holdings (search), Rentenbank (search), Aurae Impact (search), ABN AMRO Bank (search), and EIFO (search). This diverse investor base reflects growing confidence in the commercial viability of science-led sustainability solutions.
"We are seeing a clear evolution in how investors approach climate and industrial innovation," said Alexander Hoffmann, General Partner at Forbion (search). "Biotechnology is moving beyond healthcare to tackle global challenges in food, materials, and resource efficiency. The strong demand for Forbion BioEconomy Fund I reflects growing confidence that science-led solutions can deliver both environmental and financial value."
Joy Faucher, General Partner at Forbion (search), emphasized the broader market shift: "Capital is shifting from software to science. With strong backing from leading institutional and strategic limited partners, we are excited to build a portfolio that leverages the power of biology and chemistry to deliver much-needed, commercially viable sustainable solutions for the planet."
Strategic Investment Focus Across Four Key Sectors
The Forbion (search) BioEconomy Fund I targets companies developing cost-effective and scalable biology-based business-to-business solutions across four strategic sectors: Food, Agriculture, Materials, and Environmental Technologies. The fund focuses on Series A and B stage companies that have demonstrated proof of concept and can replace incumbent products at price parity or better.
The fund aims to build a portfolio of 12-14 investments across Europe and North America, with the market for biotech-enabled alternatives representing a significant commercial opportunity estimated at several trillion euros in the next decade, according to McKinsey data.
Diverse Portfolio of Innovative Companies
To date, the fund has invested in five portfolio companies, each addressing critical sustainability challenges through biotechnology:
eeden (search) pioneers textile-to-textile recycling using green chemistry depolymerization technologies, addressing the textile industry's waste and sustainability challenges.
Genomines (search) leverages plant biotechnology to extract valuable metals, offering a sustainable and cost-competitive alternative to traditional mining methods.
SOLASTA Bio (search) develops novel peptides that provide bio-safe, effective, and targeted alternatives to traditional chemical pesticides.
Novameat (search) focuses on developing scalable and clean protein cuts to accelerate the transition to plant-based proteins.
PACT (search) utilizes its biomaterial platform for cost-effective, high-performance collagen-based coating solutions, initially targeting textile applications.
Addressing Industrial Decarbonization Through Biology
The fund's mandate centers on biotechnologies and green chemistries that make industrial sustainability scalable, contributing to the decarbonization of multiple industries. Each portfolio company reflects the fund's focus on replacing high-emission industrial inputs with biologically derived solutions that can be scaled without premium pricing.
The success of Forbion (search) BioEconomy Fund I signals the bioeconomy's emergence as a major vector for climate-aligned growth, where innovation, environmental performance, and investor returns converge. As global policy frameworks push for measurable decarbonization, funds like Forbion's are positioned to fill a critical financing gap between lab-scale innovation and industrial-scale adoption.
Strengthening Europe's Bioindustrial Innovation Hub
The fund strengthens Europe's position as a global hub for bioindustrial innovation, complementing national strategies to reduce dependence on petrochemical-derived materials and achieve climate neutrality by mid-century. Forbion (search)'s latest fund extends the firm's legacy in life sciences toward a broader planetary health mission, bridging human health, resource efficiency, and industrial sustainability.